AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LOSARTAN POTASSIUM USP
6 registrations across 3 African markets— 2 active
Markets with LOSARTAN POTASSIUM USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Losakind-50 tablets Film-coated Tablets | 🇿🇲Zambia | Mankind Pharma Ltd | active | Jun 2030 |
| Losa 50 tablets Film Coated Tablets | 🇿🇲Zambia | Lincoln Pharmaceuticals Limited | active | Nov 2029 |
| LOSARTAN_POTASSIUM 50MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| ZYLTAN-50 50MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| LOSARTAN POTASSIUM 50MG TABLET/2X14 | 🇳🇬Nigeria | FIRST J POCCO PHARM LTD. 89 | expired | Jan 2022 |
| CZARTAN H TABLET TABLET/5X10 | 🇳🇬Nigeria | JMD PHARMALINKS LIMITED 2 | expired | Jan 2021 |
LOSARTAN POTASSIUM USP in Africa — Regulatory Overview
LOSARTAN POTASSIUM USP is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 2 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.